Trade Proto Labs, Inc. Common stock - PRLB CFD

Trading Conditions
Spread0.23
Long position overnight fee
Long position overnight fee

Margin. Your investment
$1,000.00
Overnight fee
Charges from full value of position
-0.026179 %
(-$1.05)

Trade size with leverage ~ $5,000.00

Short position overnight fee ~ $4,000.00


-0.026179%
Short position overnight fee
Short position overnight fee

Margin. Your investment
$1,000.00
Overnight fee
Charges from full value of position
0.003957 %
($0.16)

Trade size with leverage ~ $5,000.00

Short position overnight fee ~ $4,000.00


0.003957%
Overnight fee time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin20
Stock exchangeUnited States of America
Commission on trade10%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close30.63
Open30.82
1-Year Change6.68%
Day's Range30.58 - 31.22

Proto Labs, Inc. Common stock Company profile

About Proto Labs Inc

Proto Labs, Inc. is a digital manufacturer of custom prototypes and on-demand production parts. The Company's segments include United States, Europe and Japan. Its primary manufacturing product lines include injection molding, computer numerical control (CNC) machining, three dimensional (3D) printing and sheet metal. It targets its products to product developers and engineers who use 3D computer aided design (3D CAD) software to design products across a range of end-markets. The Company's injection molding product line uses its 3D CAD-to-CNC machining technology for the automated design and manufacture of molds. Its CNC machining product line uses CNC machines to manufacture custom metal and plastic arts. Its 3D printing product line includes a range of technologies in plastics and metals, stereolithography and selective laser sintering, among others. Its sheet metal product line includes quick-turn and e-commerce-enabled custom sheet metal parts and assemblies.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Proto Labs Inc revenues increased 12% to $488.1M. Net income decreased 34% to $33.4M. Revenues reflect United states segment increase of 11% to $384.5M, Europe segment increase of 21% to $90.4M. Net income was offset by Europe segment income decrease of 94% to $730K, Corporate segment loss increase of 15% to $58.4M, United states segment income decrease of 1% to $98M.

Equity composition

Common Stock $.001 Par, 02/12, 150M auth., 23,187,708 issd. Insiders own aprrox.77.4%.